Two European partners will soon be vying for dominance in a new battleground: vaccines to protect travelers against a painful ...
A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
An official statement from the department says the city has only received a limited supply of the FDA-approved Jynneos monkeypox vaccine, produced by the Danish biotechnology firm Bavarian Nordic ...
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in ...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN ® smallpox vaccine to the strategic ...
To confirm the efficacy of the monkeypox vaccine, Bavarian Nordic will collect data from ... company would be able to absorb the increasing demand despite having only a single production facility.
COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a ...
2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access ...
Ritchie Torres filed legislation this week aimed at improving the HHS' response to mpox and other health emergencies.
should routinely get Bavarian Nordic's JYNNEOS vaccine. The recommendation, however, has not yet been approved by CDC ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of ...
In February 2024, the Committee for Medicinal Products for Human Use (CHMP) under EMA granted accelerated assessment for the MAA for the CHIKV VLP vaccine candidate, which Bavarian Nordic plans to ...